SOLICITATION NOTICE
B -- FDA-09-223-SOL-00042
- Notice Date
- 4/23/2009
- Notice Type
- Presolicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-09-223-SOL-00042
- Archive Date
- 5/23/2009
- Point of Contact
- Dominique H Malone, Phone: (301) 827-7227, Doreen Williams ,, Fax: 301-827-7106
- E-Mail Address
-
dominique.malone@fda.hhs.gov, doreen.williams@fda.hhs.gov
- Small Business Set-Aside
- N/A
- Description
- A. Background The Food and Drug Administration (FDA) intends to solicit proposals for a contractor to provide Center for Food Safety and Applied Nutrition CFSAN with a broad overview of the presence, frequency and levels of microbial pathogens in foods with emphasis on produce commodities. Outbreaks due to the contamination of produce have received a heightened interest from the American public. B. Scope of Work The Food and Drug Administration, Center for Food Safety and Applied Nutrition (CFSAN) has specific regulatory responsibilities directed at ensuring the safety of food, food additive, dietary supplement, and cosmetic products. In part, CFSAN maintains an active research program for the purpose of developing and applying technologies to detect, to identify and evaluate microbial hazards that may contaminate products either naturally or intentionally. This contract is intended to provide CFSAN with a broad overview of the presence, frequency and levels of microbial pathogens in foods with emphasis on produce commodities. Outbreaks due to the contamination of produce have received a heightened interest from the American public. This contract should provide significant data on the prevalence of selected bacterial pathogens in a wide variety of produce commodities and a broad view of the presence of Salmonella in tomatoes. The overarching objectives of this contract are to provide significant baseline data of potential microbiological hazards associated with the consumption of raw and minimally processed produce and to identify other microbial-related environmental and food-related risks. In order to better understand how pervasive microbial pathogens are in fresh produce commodities the objective of this contract is to analyze selected foods for the presence of Salmonella, Shigella, and Escherichia coli O157:H7. As for ready-to-eat (RTE) foods, our focus will be on Listeria monocytogenes. Our plans include the generation of a database for these select produce as to the frequency of isolation/detection of the aforementioned pathogens in each commodity as it relates to its geographical location and growing season. The emphasis of this contract is to focus on obtaining data that will reflect a broader scope of the frequency and levels of bacteriological human pathogens that have historically been associated with fresh produce commodities and a variety of RTE foods. In order to better understand how pervasive microbial pathogens are in fresh produce commodities the objective of this contract is to analyze selected foods for the presence of Salmonella, Shigella, and Escherichia coli O157:H7. As for RTE foods, our focus will be on Listeria monocytogenes. Our plans include the generation of a database for these select produce as to the frequency of isolation/detection of the aforementioned pathogens in each commodity as it relates to its geographical location and growing season. The impact of such data collection could have an affect on any Produce Safety Regulatory Options Developed by FDA with the following parameters: Consistent across the U.S., based on sound science, overarching (most commonly consumed fresh produce), accommodate specifics (commodity, region, operations, practices, size of establishment), and allow the U.S. to meet its obligations under WTO SPS. C. Additional Information It is anticipated that one (1) Indefinite Delivery Indefinite Quantity (IDIQ) contract will be awarded with a one (1) year base period and four (4) option years. This announcement is not a request for proposal (RFP). FDA anticipates release of the RFP on or around May 8, 2009 and it will be available on the Federal Business Opportunities (FedBizOpps) website. The anticipated award date for this effort is on or before or after July 1, 2009.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=e3a5c4e1b254f0c3e04e7e31810c9234&tab=core&_cview=1)
- Place of Performance
- Address: CPK1 RM3D039 HFS-710, College Park, Maryland, MD, United States
- Record
- SN01800129-W 20090425/090423215507-e3a5c4e1b254f0c3e04e7e31810c9234 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |